Physician profile
John Tierney
NPI 1417913047
$134,063.48
in general payments reported to CMS, 2019-2025
24 companies · $2,174 in 2025
The $2,174 reported for 2025 was more than what 94% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $27K · 2020: $88K · 2021: $576 · 2022: $8,264 · 2023: $2,224 · 2024: $6,371 · 2025: $2,174.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,000 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,800 · Travel and Lodging: $1,537 · Food and Beverage: $1,431.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,000.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,800.00 |
| Travel and Lodging | $1,537.04 |
| Food and Beverage | $1,431.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Anika Therapeutics, INC. | $128,595.48 | 2019-2025 | Tactoset, Integrity, Integrity Implant |
| Kairos Surgical INC | $1,264.40 | 2023 | |
| Depuy Synthes Products, INC. | $1,000.00 | 2019 | |
| Smith+Nephew, INC. | $553.65 | 2019-2024 | N/A |
| Arthrex, INC. | $481.76 | 2019-2023 | |
| Pacira Pharmaceuticals Incorporated | $379.46 | 2021-2023 | Iovera, Zilretta, Exparel |
| Pacira Therapeutics, INC. | $248.10 | 2019-2021 | |
| Heron Therapeutics, INC. | $242.19 | 2023-2024 | Zynrelef |
| Linvatec Corporation | $185.11 | 2023 | Biobrace 23mm |
| Osteoremedies, LLC | $170.66 | 2025 | Remedy Spacer, Biowash Surgical Irrigation, Osteoboost Select 5cc |
| Stryker Corporation | $162.25 | 2021-2025 | Alphavent |
| Exactech, INC. | $151.33 | 2022 | |
| Arthrosurface Incorporated | $111.64 | 2020 | |
| Vericel Corporation | $108.86 | 2022 | |
| Bone Support INC. | $107.89 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Conformis, INC. | $98.77 | 2022 | |
| Acumed LLC | $82.89 | 2020 | |
| Bioventus LLC | $36.49 | 2019-2022 | |
| Fidia Pharma USA INC. | $23.32 | 2023 | Hymovis, Triluron |
| Orthofix Medical, INC. | $17.67 | 2025 | Physio-Stim |
| Baudax Bio INC. | $14.85 | 2022 | |
| Pfizer INC. | $14.55 | 2020 | |
| Depuy Synthes Sales INC. | $12.16 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$168,565.96 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Tierney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.